Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Psych Congress Europe to Take Place in Barcelona, Spain
12/23/2021
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be held in Barcelona, Spain, February 23-25 and promises to connect the global mental healthcare community with updated approaches in practical psychopharmacology.
Psych Congress Europe will be...
12/23/2021
Psych Congress Network
News
Patients With MDD Show Rapid Symptom Improvement With Investigational Drug Zuranolone
12/22/2021
Patients taking zuranolone saw rapid improvements in depressive and elevated anxiety symptoms, according to data presented by Sage Therapeutics and Biogen.
Patients taking zuranolone saw rapid improvements in depressive and elevated anxiety symptoms, according to data presented by Sage Therapeutics and Biogen.
Patients taking zuranolone saw...
12/22/2021
Psych Congress Network
News
ADHD Improvement After Few-Foods Diet Correlates With Precuneus Activation
12/21/2021
According to new research, behavior improvements in children with ADHD following a few-foods diet were reflected in their brain activity
According to new research, behavior improvements in children with ADHD following a few-foods diet were reflected in their brain activity
According to new research,...
12/21/2021
Psych Congress Network

Advertisement

News
FDA Approves CAPLYTA® For Treatment of Bipolar Depression
12/20/2021
The US Food and Drug Administration (FDA) has approved Intra-Cellular Therapies, Inc’s CAPLYTA® (lumaterperone) for the treatment of adult bipolar depression.
The US Food and Drug Administration (FDA) has approved Intra-Cellular Therapies, Inc’s CAPLYTA® (lumaterperone) for the treatment of adult bipolar depression.
The US Food and Drug...
12/20/2021
Psych Congress Network
News
Adult ADHD Increases Risk for a Wide Range of Physical Conditions
12/20/2021
Adults with ADHD are at increased risk of a broad range of physical health conditions, the strongest associations for nervous system disorders and respiratory diseases.
Adults with ADHD are at increased risk of a broad range of physical health conditions, the strongest associations for nervous system disorders and respiratory diseases.
Adults with ADHD are at...
12/20/2021
Psych Congress Network
News
Distressing Psychotic-like Experiences in Youth Signal Need for Intervention
12/20/2021
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like...
12/20/2021
Psych Congress Network

Advertisement

News
PharmaTher Progresses Toward Phase 2 Trial of Patch to Deliver LSD Doses
12/15/2021
PharmaTher Holdings has successfully completed its first research study of the use of its proprietary microneedle patch for intradermal delivery of psychedelics to administer LSD. The company plans to file an investigational new drug...
PharmaTher Holdings has successfully completed its first research study of the use of its proprietary microneedle patch for intradermal delivery of psychedelics to administer LSD. The company plans to file an investigational new drug...
PharmaTher Holdings has...
12/15/2021
Psych Congress Network
News
During Stay-at-Home Orders, Child Abuse Rate Tripled
12/14/2021
The number of pediatric trauma patients who were suspected victims of child abuse tripled during COVID-19 pandemic stay-at-home orders suggests an analysis of 9 level I pediatric trauma centers.
The number of pediatric trauma patients who were suspected victims of child abuse tripled during COVID-19 pandemic stay-at-home orders suggests an analysis of 9 level I pediatric trauma centers.
The number of pediatric trauma...
12/14/2021
Psych Congress Network
News
CBT-I Halves Likelihood of Depression in Older Adults
12/13/2021
Cognitive behavioral therapy for insomnia (CBT-I) is beneficial for preventing incident and recurrent depression in older adults with insomnia disorder, according to recent study findings.
Cognitive behavioral therapy for insomnia (CBT-I) is beneficial for preventing incident and recurrent depression in older adults with insomnia disorder, according to recent study findings.
Cognitive behavioral therapy for...
12/13/2021
Psych Congress Network

Advertisement

News
Abnormal Pattern of Emotional Regulation Identified in People With Schizophrenia
12/13/2021
Patients with schizophrenia tend to regulate low-level negative emotions too much and high-level negative emotions too little, according to new study findings.
Patients with schizophrenia tend to regulate low-level negative emotions too much and high-level negative emotions too little, according to new study findings.
Patients with schizophrenia tend...
12/13/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use